Phathom Shares Plunge 23% After BDR Suit Over VOQUEZNA Exclusivity
Phathom Pharmaceuticals said BDR Pharmaceuticals sued the FDA over exclusivity for its key drug VOQUEZNA. Phathom shares fell roughly 23% on Friday.
Shares of Phathom Pharmaceuticals (PHAT) plunged roughly 23% on Friday after the company disclosed that BDR Pharmaceuticals had sued the U.S. Food and Drug Administration over exclusivity for its key drug VOQUEZNA.Phathom said BDR Pharmaceuticals International Pvt. Ltd. filed suit in the U.S.
Distr…